COVID-19: China Healthcare Implications for Private Equity Investors Presentations July 14, 2020 Helen Chen Justin Wang Stephen Sunderland
Healthcare Services Presentations COVID-19 Impact on Asia-Pacific Hospitals: Final Edition July 16, 2020 The top concerns for a number of hospitals (40%-50%) have shifted towards staff wellness, staff capacity and hospital finances due to revenue loss from…
Life Sciences & Pharma Executive Insights Biopharma Launch Trends — Lessons Learned From L.E.K.’s Launch Monitor December 18, 2020 The cost of drug development continues to rise and the probability of creating new blockbuster therapies is not getting any easier.
Life Sciences & Pharma Executive Insights European Drug Pricing and Market Access in a COVID-19 World October 14, 2020 On 3 June 2020, Médecins Sans Frontières (MSF) issued an appeal urging world leaders to ensure that pharmaceutical companies sell any COVID-19 vaccines at…
MedTech Executive Insights Impact of COVID-19 on the Australian MTP Sector August 21, 2020 The COVID-19 crisis has had a strongly negative impact on the MTP sector, as it has on many other parts of the Australian economy.
Life Sciences & Pharma Presentations China Hospital Priorities — Strategic Themes and Implications for Medtechs September 18, 2020 L.E.K., in collaboration with APACMed, conducted a survey with ~400 hospital executives across both public and private hospitals in key APAC markets.
Life Sciences & Pharma Video / Webinar How Have Hospitals Across APAC Adapted to the Impact of COVID-19? April 8, 2021 L.E.K. Consulting’s survey of hospital executives at private and public hospitals in the Asia Pacific region reveals three key themes.
